New hope for rare hormone disorder: drug may cut pill burden

This study tested a new drug, palopegteriparatide, in 90 adults with chronic hypoparathyroidism, a condition where the body lacks parathyroid hormone. The goal was to see if the drug could help patients stop taking daily vitamin D and calcium supplements. Results showed many patients were able to become independent from these supplements for at least four weeks, reducing their daily pill load. The drug was given by injection and monitored for safety over 14 months.